Stockreport

Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights [Yahoo! Finance]

Cue Biopharma, Inc.  (CUE) 
US:NASDAQ Investor Relations: cuebiopharma.gcs-web.com/news-releases
PDF of therapeutic biologics to selectively modulate disease-specific T cells, today reported fourth quarter and full year 2023 financial results. Presented additional pos [Read more]